Related references
Note: Only part of the references are listed.Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center
Shakya Bhattacharjee et al.
NEUROHOSPITALIST (2019)
DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice
Jacob Yomtoob et al.
PARKINSONISM & RELATED DISORDERS (2018)
Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center
Allison K. Graebner et al.
NEURODEGENERATIVE DISEASES (2017)
Therapeutic Interventions for Vascular Parkinsonism: A Systematic Review and Meta-analysis
Adan Miguel-Puga et al.
FRONTIERS IN NEUROLOGY (2017)
Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis
Giovanni Rizzo et al.
NEUROLOGY (2016)
Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center
Srivadee Oravivattanakul et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2016)
Clinical routine use of dopamine transporter imaging in 516 consecutive patients
Claire Thiriez et al.
JOURNAL OF NEUROLOGY (2015)
Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?
Danny Bega et al.
NEURODEGENERATIVE DISEASES (2015)
Experience with DaTscan at a tertiary referral center
Suja Sadasivan et al.
PARKINSONISM & RELATED DISORDERS (2015)
[123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis
F. Brigo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
Kenneth Marek et al.
NEUROLOGY (2014)
Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline
Michael Grundman et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2013)
Changes in Clinical Management and Diagnosis following DaTscan™ SPECT Imaging in Patients with Clinically Uncertain Parkinsonian Syndromes: A 12-Week Follow-Up Study
Andreas Kupsch et al.
NEURODEGENERATIVE DISEASES (2013)
The relationship between cerebral vascular disease and parkinsonism: The VADO study
A. Antonini et al.
PARKINSONISM & RELATED DISORDERS (2012)
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases
Friederike Sixel-Doering et al.
JOURNAL OF NEUROLOGY (2011)
Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes
C. Bairactaris et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
The National Oncologic PET Registry (NOPR): Design and analysis plan
Bruce E. Hillner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Rate of clinical progression in Parkinson's disease. A prospective study
Anette Schrag et al.
MOVEMENT DISORDERS (2007)
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
Vicky L. Marshall et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome
S. Hesse et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes:: study on 72 patients
M Plotkin et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes
AM Catafau et al.
MOVEMENT DISORDERS (2004)
(123I) β-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome -: Unmasking an early diagnosis
DL Jennings et al.
ARCHIVES OF NEUROLOGY (2004)
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand
A Lokkegaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Share Paper
